Price $31.45 |
Market Cap
635.8M
|
Sector Health Care |
Div. Growth
20.50%
|
|
P/E
34.6
|
P/B
4.66
|
P/S
5.61
|
Dividend %
1.10%
|
|
P/CF
88.1
|
P/FCF
46.6
|
Op. Cash Flow
19.5K
|
FCF
0.6
|
|
Op. Margin
25.60%
|
Net Margin
20.80%
|
ROE
18.00%
|
ROI
17.10%
|
|
ROA
15.40%
|
EPS Growth
26.80%
|
Current Ratio
4.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $22.10 | - | - | 8.35B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.26 | - | - | 12.3M | Strong Buy |
| Hologic, Inc. (HOLX) | $49.85 | - | - | 13.59B | Strong Buy |
| Biomerica, Inc. (BMRA) | $2.92 | - | - | 33.8M | Strong Buy |
| American Renal Associates Hold (ARA) | $6.64 | - | - | 240.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
